Bioharmony, Boehringer partner to develop antimicrobials

Antimicrobial company Bioharmony Therapeutics Inc. (New York, N.Y.) partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to develop bacteriophage lysins to treat systemic multidrug-resistant Acinetobacter infections.